The Cannabinoid CB1/CB2 Agonist WIN55212.2 Promotes Oligodendrocyte DifferentiationIn Vitroand Neuroprotection During the Cuprizone-Induced Central Nervous System Demyelination

CNS Neuroscience and Therapeutics - United Kingdom
doi 10.1111/cns.12506
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Cannabinoid CB1 Receptor-Interacting Proteins: Novel Targets for Central Nervous System Drug Discovery?

British Journal of Pharmacology
Pharmacology
2010English

Cannabinoid CB1/CB2 Receptors in the Heart: Expression, Regulation, and Function

2016English

Microglial Hv1 Proton Channel Promotes Cuprizone-Induced Demyelination Through Oxidative Damage

Journal of Neurochemistry
BiochemistryMolecular NeuroscienceCellular
2015English

Neural Stem Cells of the Subventricular Zone Contribute to Neuroprotection of the Corpus Callosum After Cuprizone-Induced Demyelination

Journal of Neuroscience
Neuroscience
2019English

Spatial Distribution of Cannabinoid Receptor Type 1 (CB1) in Normal Canine Central and Peripheral Nervous System

PLoS ONE
Multidisciplinary
2017English

Gut Commensalism, Cytokines, and Central Nervous System Demyelination

Journal of Interferon and Cytokine Research
MedicineVirologyImmunologyCell Biology
2014English

MicroRNA-23a Promotes Myelination in the Central Nervous System

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2013English

Inflammation Induced by Innate Immunity in the Central Nervous System Leads to Primary Astrocyte Dysfunction Followed by Demyelination

Acta Neuropathologica
Forensic MedicineMolecular NeurosciencePathologyNeurologyCellular
2010English

Functional Characterization of the Novel Cannabinoid Receptor GPR55 and Its Modulation by CB1 and CB2 Receptors

BMC Pharmacology
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy